USD10
LAB Shares
About Standard BioToolsStandard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
USD10
LAB Shares
About Standard BioToolsStandard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$367.14M
OPEN PRICE
$0.9539
LOW (1Y)
$0.92
HIGH (1Y)
$1.72
LOW (24H)
$0.95
HIGH (24H)
$1.01
VOLUME (24H)
$3.78M
183.44%
Price history
Time | Price | Change |
|---|---|---|
Today | $0.9539 | |
1 Day | $0.9613 | |
1 Week | $0.95 | |
1 Month | $1.14 | |
1 Year | $1.15 |
Past performance is not a reliable indicator of future results.